地中海饮食改善冠心病患者内皮功能:CORDIOPREV随机对照试验分析
CORDIOPREV试验纳入1002例冠心病患者,805例完成基线内皮功能评估并随机接受地中海饮食或低脂饮食,1年后复测。地中海饮食组血流介导舒张(FMD)为3.83%(95%CI 2.91-4.23),低脂饮食组为1.16%(95%CI 0.80-1.98),组间差异2.63%(95%CI 1.89-3.40,p=0.011),且严重内皮功能障碍者亦获益。
要点
- 地中海饮食较低脂饮食显著改善冠心病患者肱动脉FMD。
- 地中海饮食升高内皮祖细胞、降低内皮微颗粒,改善血管稳态。
- 体外实验显示地中海饮食减少氧化应激、凋亡和衰老,促进增殖和血管新生。
核心结论
- 地中海饮食较低脂饮食更好地调节冠心病患者内皮功能,改善血管稳态平衡。
- 即使存在严重内皮功能障碍的患者,地中海饮食仍与内皮功能改善相关。
研究设计与样本
- CORDIOPREV为正在进行的前瞻性、随机、单盲、对照试验,纳入1002例冠心病患者。
- 本报告为次要结局分析,805例完成基线内皮功能评估并随机接受地中海饮食或低脂饮食,1年后复测FMD。
- 地中海饮食构成:35%脂肪、22%单不饱和脂肪酸、<50%碳水化合物;低脂饮食:28%脂肪、12%单不饱和脂肪酸、>55%碳水化合物。
- 另定量内皮微颗粒和内皮祖细胞,并在24例预选患者中评估体外细胞过程及相关调节因子。
主要发现
- 地中海饮食组FMD为3.83%(95%CI 2.91-4.23),低脂饮食组为1.16%(95%CI 0.80-1.98),组间差异2.63%(95%CI 1.89-3.40,p=0.011)。
- 地中海饮食组内皮祖细胞较高(组间差异1.64%,95%CI 0.79-2.13,p=0.028),内皮微颗粒较低(组间差异-755 EMPs/μl,95%CI -1,010至-567,p=0.015)。
- 地中海饮食组细胞内活性氧较低(组间差异11.1,95%CI 2.5-19.6,p=0.010),细胞凋亡较低(组间差异-20.2,95%CI -26.7至-5.11,p=0.013),衰老较低(18.0,95%CI 3.57-25.1,p=0.031)。
- 地中海饮食组细胞增殖较高(组间差异11.3,95%CI 4.51-13.5,p=0.011),血管新生总主段长度较高(组间差异549,95%CI 110-670,p=0.022)。
- 每种饮食干预与调节内皮功能障碍相关生物过程的表观遗传和蛋白质组因子变化各具特征。
临床怎么用
- 对冠心病患者,地中海饮食可作为保护内皮功能的饮食策略。
- 内皮功能评估可作为饮食干预效果的评价指标之一。
局限性
- 本分析为CORDIOPREV研究的亚组分析,结果应谨慎解读。
- 探索性分析存在假阳性可能。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Endothelial dysfunction is a crucial step in atherosclerosis development, and its severity is determinant for the risk of cardiovascular recurrence. Diet may be an effective strategy to protect the endothelium, although there is no consensus about the best dietary model. The CORonary Diet Intervention with Olive oil and cardiovascular PREVention (CORDIOPREV) study is an ongoing prospective, randomized, single-blind, controlled trial in 1,002 coronary heart disease (CHD) patients, whose primary objective is to compare the effect of 2 healthy dietary patterns (low-fat versus Mediterranean diet) on the incidence of cardiovascular events. Here, we report the results of one secondary outcome of the CORDIOPREV study: to evaluate the effect of these diets on endothelial function, assessed by flow-mediated dilation (FMD) of the brachial artery. METHODS AND FINDINGS: From the total participants taking part in the CORDIOPREV study, 805 completed endothelial function study at baseline and were randomized to follow a Mediterranean diet (35% fat, 22% monounsaturated fatty acids [MUFAs], and <50% carbohydrates) or a low-fat diet (28% fat, 12% MUFAs, and >55% carbohydrates), with endothelial function measurement repeated after 1 year. As secondary objectives and to explore different underlying mechanisms in the modulation of endothelial function, we quantified endothelial microparticles (EMPs) and endothelial progenitor cells (EPCs) and evaluated, in 24 preselected patients, in vitro cellular processes related to endothelial damage (reactive oxygen species, apoptosis, and senescence) and endothelial repair (cell proliferation and angiogenesis), as well as other modulators (micro-RNAs [miRNAs] and proteins). Patients who followed the Mediterranean diet had higher FMD (3.83%; 95% confidence interval [CI]: 2.91-4.23) compared with those in the low-fat diet (1.16%; 95% CI: 0.80 to 1.98) with a difference between diets of 2.63% (95% CI: 1.89-3.40, p = 0.011), even in those patients with severe endothelial dysfunction. We observed higher EPC levels (group difference: 1.64%; 95% CI: 0.79-2.13, p = 0.028) and lower EMPs (group difference: -755 EMPs/μl; 95% CI: -1,010 to -567, p = 0.015) after the Mediterranean diet compared with the low-fat diet in all patients. We also observed lower intracellular reactive oxygen species (ROS) production (group difference: 11.1; 95% CI: 2.5 to 19.6, p = 0.010), cellular apoptosis (group difference: -20.2; 95% CI: -26.7 to -5.11, p = 0.013) and senescence (18.0; 95% CI: 3.57 to 25.1, p = 0.031), and higher cellular proliferation (group difference: 11.3; 95% CI: 4.51 to 13.5, p = 0.011) and angiogenesis (total master segments length, group difference: 549; 95% CI: 110 to 670, p = 0.022) after the Mediterranean diet than the low-fat diet. Each dietary intervention was associated with distinct changes in the epigenetic and proteomic factors that modulate biological process associated with endothelial dysfunction. The evaluation of endothelial function is a substudy of the CORDIOPREV study. As in any substudy, these results should be treated with caution, such as the potential for false positives because of the exploratory nature of the analyses. CONCLUSIONS: Our results suggest that the Mediterranean diet better modulates endothelial function compared with a low-fat diet and is associated with a better balance of vascular homeostasis in CHD patients, even in those with severe endothelial dysfunction. CLINICAL TRIAL REGISTRATION: URL, http://www.cordioprev.es/index.php/en. clinicaltrials.gov number NCT00924937.
引用
- Yubero-Serrano EM, Fernandez-Gandara C, Garcia-Rios A, et al. Mediterranean diet and endothelial function in patients with coronary heart disease: An analysis of the CORDIOPREV randomized controlled trial. PLoS Med. 2020. PMID: 32903262. doi:10.1371/journal.pmed.1003282
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。